Tyndall signs landmark research collaboration with West pharma
15 January 2019
L-R: Chris Evans, VP of research, West Pharma; Eric Resnick, VP and chief technology officer, West Pharma; Carlo Webster, senior strategic business development executive, Tyndall; Dr Alex Lyness, manager, research and technology, West Pharma; Andrea Bocchino, researcher, Tyndall; Dr Conor O’Mahony, senior research scientist, Tyndall; Dr Eamonn Hawe, ICT for health programme manager, Tyndall.
Tyndall National Institute has signed a Research & Development (R&D) collaboration agreement with West Pharmaceutical Services, Inc, to work on future developments of drug delivery systems for injectable medicines.
Range of transformational medical devices
The collaboration will apply Tyndall’s multidisciplinary research in information and communication technology (ICT) to a range of transformational medical devices in development at West.
This will enable West, a global leader in the design and manufacture of drug containment and delivery systems, to meet emerging trends in the healthcare industry.
“This is an exciting opportunity for West to engage with Tyndall National Institute,” said Chris Evans, VP Innovation, West.
“We are delighted to collaborate with one of Europe’s leading ICT research centers and look to bolster our research and development footprint in Ireland.
“We have been impressed by the talented team that has come together to devise the joint-proposal and are grateful to the Irish funding body who has recognized the vision and technology we are set to co-develop.”
The two-year project will employ a team of postdoctoral researchers, who will be working at Tyndall in partnership with West. This highly collaborative project is to be co-funded by an Enterprise Ireland Innovation Partnership with IDA support.
Intersection between healthcare and ICT fields
Carlo Webster, senior strategic business executive, Tyndall National Institute, said: “The Tyndall–West collaboration has arrived at the right time and at the intersection between healthcare and ICT fields.
“It is becoming increasingly apparent with each new generation of products coming on to the market that smart systems are required. The collaboration is a perfect example of where West identifies unmet needs from the market and partners with Tyndall to deliver the technical competency and innovative solutions that are required.”
Dr Conor O’Mahony, senior research scientist and project lead, said: “We look forward to developing technologies that will help improve how patients take their medicines in the future. West is an excellent partner for the team and their vision is aligned with the research team at Tyndall.”
West has a presence in Ireland and employs more than 700 people across two different manufacturing sites in Dublin and Waterford.http://www.engineersjournal.ie/2019/01/15/tyndall-signs-landmark-research-collaboration-with-west-pharma/http://www.engineersjournal.ie/wp-content/uploads/2018/12/a-aaaaaat-1024x768.jpghttp://www.engineersjournal.ie/wp-content/uploads/2018/12/a-aaaaaat-300x300.jpgNewsbiopharma,ICT,Tyndall National Institute